Kyverna Therapeutics, Inc.
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell KYTX and other ETFs, options, and stocks.About KYTX
Kyverna Therapeutics, Inc. is a cell therapy clinical-stage biotechnology company, which engages in the provision of treatments and potential cures for serious autoimmune diseases. The company was founded in June 2018 and is headquartered in Emeryville, CA.
KYTX Key Statistics
Stock Snapshot
Kyverna Therapeutics, Inc.(KYTX) stock is priced at $8.87, giving the company a market capitalization of 535.5M. It carries a P/E multiple of -2.43.
During the trading session on 2026-04-04, Kyverna Therapeutics, Inc.(KYTX) shares reached a daily high of $9.17 and a low of $8.30. At a current price of $8.87, the stock is +6.9% higher than the low and still -3.3% under the high.
Trading volume for Kyverna Therapeutics, Inc.(KYTX) stock has reached 753.95K, versus its average volume of 782.98K.
The stock's 52-week range extends from a low of $1.78 to a high of $13.67.
The stock's 52-week range extends from a low of $1.78 to a high of $13.67.
Analyst ratings
100%
of 6 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.